🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Viatris Limited — Licensed Medicines

194 medicines held by Viatris Limited on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 194 products held by Viatris Limited
MedicineActive substanceLicence holderStatus
Rivaroxaban Viatris 20 mg film-coated tablets
EU/1/21/1588/041-054
 Rivaroxaban Viatris Limited —
Rosuvastatin 10 mg film-coated tablets
PA23266/073/002
 Rosuvastatin Viatris Limited Not marketed
Rosuvastatin 20 mg film-coated tablets
PA23266/073/003
 Rosuvastatin Viatris Limited Not marketed
Rosuvastatin 40 mg film-coated tablets
PA23266/073/004
 Rosuvastatin Viatris Limited Not marketed
Rosuvastatin 5 mg film-coated tablets
PA23266/073/001
 Rosuvastatin Viatris Limited Not marketed
Rosuvastatin Viatris 10 mg film-coated tablets
PA23266/003/002
 Rosuvastatin Viatris Limited Marketed
Rosuvastatin Viatris 20 mg film-coated tablets
PA23266/003/003
 Rosuvastatin Viatris Limited Marketed
Rosuvastatin Viatris 40 mg film-coated tablets
PA23266/003/004
 Rosuvastatin Viatris Limited Marketed
Rosuvastatin Viatris 5 mg film-coated tablets
PA23266/003/001
 Rosuvastatin Viatris Limited Marketed
Sevelamer Carbonate 800 mg film coated tablets
PA23266/044/001
 Sevelamer carbonate Viatris Limited Marketed
Simvastatin 10 mg Film-coated Tablets
PA23266/047/001
 Simvastatin Viatris Limited Marketed
Simvastatin 20 mg Film-coated Tablets
PA23266/047/002
 Simvastatin Viatris Limited Marketed
Simvastatin 40 mg Film-coated Tablets
PA23266/047/003
 Simvastatin Viatris Limited Marketed
Simvastatin 80 mg Film-coated Tablets
PA23266/047/004
 Simvastatin Viatris Limited Not marketed
Sirdupla 25 microgram/125 microgram per metered dose pressurised inhalation, suspension
PA23266/020/001
 SALMETEROL XINAFOATE, Fluticasone propionate Viatris Limited Marketed
Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension
PA23266/020/002
 SALMETEROL XINAFOATE, Fluticasone propionate Viatris Limited Marketed
Sitagliptin Viatris 100 mg film-coated tablets
PA23266/031/003
 Sitagliptin Viatris Limited Marketed
Sitagliptin Viatris 25 mg film-coated tablets
PA23266/031/001
 Sitagliptin Viatris Limited Marketed
Sitagliptin Viatris 50 mg film-coated tablets
PA23266/031/002
 Sitagliptin Viatris Limited Marketed
Sormon 60 mg Prolonged-release Tablets
PA23266/051/001
 Isosorbide-5-mononitrate Viatris Limited Marketed
Sotoger 80mg Tablets
PA23266/014/001
 SOTALOL HYDROCHLORIDE Viatris Limited Marketed
Talmanco 20 mg film-coated tablets
EU/1/16/1153/001-004
 Tadalafil Viatris Limited —
Tamoxifen 20 mg tablets
PA23266/052/001
 Tamoxifen Viatris Limited Marketed
Tamsulosin 400 micrograms Modified-release Capsules, Hard
PA23266/016/001
 Tamsulosin hydrochloride Viatris Limited Marketed
Tavager 500 mg film-coated tablets
PA23266/063/001
 Levofloxacin Viatris Limited Marketed
Tenofovir disoproxil Viatris 245 mg film-coated tablets
EU/1/16/1129/001
 Tenofovir disoproxil Viatris Limited —
Tiotropium Viatris 18 microgram, inhalation powder, hard capsule
PA23266/007/001
 Tiotropium bromide Viatris Limited Not marketed
Tobi Podhaler 28 mg inhalation powder, hard capsules
EU/1/10/652/001-003
 Tobramycin Viatris Limited —
Valsartan Viatris 160 mg Film-coated Tablets
PA23266/006/003
 Valsartan Viatris Limited Marketed
Valsartan Viatris 320 mg Film-coated Tablets
PA23266/006/004
 Valsartan Viatris Limited Marketed
Valsartan Viatris 40 mg Film-coated Tablets
PA23266/006/001
 Valsartan Viatris Limited Marketed
Valsartan Viatris 80 mg Film-coated Tablets
PA23266/006/002
 Valsartan Viatris Limited Marketed
Vancomycin Viatris 1000 mg, powder for solution for infusion
PA23266/004/002
 Vancomycin Viatris Limited Marketed
Vancomycin Viatris 500 mg, powder for solution for infusion
PA23266/004/001
 Vancomycin Viatris Limited Marketed
Venlofex 150 mg prolonged-release hard capsules
PA23266/049/002
 Venlafaxine hydrochloride Viatris Limited Marketed
Venlofex 75 mg prolonged-release hard capsules
PA23266/049/001
 Venlafaxine hydrochloride Viatris Limited Marketed
Xatger 10mg prolonged release tablets
PA23266/039/001
 Alfuzosin hydrochloride Viatris Limited Marketed
Zeliravel 400 microgram hard modified-release capsules
PA23266/070/001
 Tamsulosin hydrochloride Viatris Limited Not marketed
Zimoclone 7.5 mg film-coated tablets
PA23266/009/001
 Zopiclone Viatris Limited Marketed
Zirtene 10 mg film-coated tablets
PA23266/017/001
 Cetirizine dihydrochloride Viatris Limited Marketed
Zismirt 30mg film-coated tablets
PA23266/036/001
 Mirtazapine Viatris Limited Marketed
Zonisamide Viatris 100 mg hard capsules
EU/1/16/1093/009-013
 Zonisamide Viatris Limited —
Zonisamide Viatris 25 mg hard capsules
EU/1/16/1093/001-004
 Zonisamide Viatris Limited —
Zonisamide Viatris 50 mg hard capsules
EU/1/16/1093/005-008
 Zonisamide Viatris Limited —
← 1 2 3 4

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.